With full membership, watch our educational and editorial videos, search the site, receive our newsletters, join discussions, download slides and much more.
Reducing CV Risk: What Add-On Therapies Do You Use? Click to take the survey and compare answers. The results will help us create future CME programming
How will the results of JUPITER expand the universe of cardiovascular risk evaluation? Join Drs Ballantyne, Ridker, and Chapman as they discuss this important biomarker study and its implication for clinical practice.
What's the latest on reducing residual risk? Read Dr Polsani's overview of the latest clinical trial data on management strategies for mixed dyslipidemia. Then watch Drs Davidson, Plutzky, Wierzbicki, Ballantyne and Nesto as they each give their take including reactions to data released at AHA 2008.
Join Drs Frank Sacks, Peter Jones and Theodore Mazzone as they discuss how the results of new clinical trials will affect the treatment of mixed dyslipidemia and reduce cardiovascular risk in patients with type 2 diabetes.
Acknowledgements
CME provider: Medscape.
The Mixed Dyslipidemia clinical theme is supported by an independent educational grant from Abbott Laboratories.
Steering committee
The steering committee members are active in overseeing the development and direction of this educational series.